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Summary 17 
Herpesviruses encode miRNAs that target both virus and host genes; however their role in herpesvirus 18 
biology is poorly understood. We previously identified eight miRNAs encoded by OvHV-2; the 19 
causative agent of malignant catarrhal fever (MCF) and have now investigated the role of these 20 
miRNAs in regulating expression of OvHV-2 genes that play important roles in virus biology. ORF 21 
20 (cell cycle inhibition), ORF 50 (reactivation) and ORF 73 (latency maintenance) each contain 22 
predicted targets for several OvHV-2 miRNAs. Co-transfection of miRNA mimics with luciferase 23 
reporter constructs containing the predicted targets showed the 5’ UTRs of ORF 20 and ORF 73 24 
contain functional targets for ovhv-miR-2 and ovhv2-miR-8 respectively, and the 3’UTR of ORF 50 25 
contains a functional target for ovhv2-miR-5. Transfection of BJ1035 cells (an OvHV-2 infected 26 
bovine T cell line) with the relevant miRNA mimic resulted in a significant decrease in ORF 50 and a 27 
smaller but non-significant decrease in ORF 20. However, we were unable to demonstrate a decrease 28 
in ORF 73. MCF is a disease of dysregulated lymphocyte proliferation, miRNA inhibition of ORF 20 29 
expression may play a role in this aberrant lymphocyte proliferation. The proteins encoded by ORFs 30 
50 and 73 play opposing roles in latency, it has been hypothesized that miRNA-induced inhibition of 31 
virus genes acts to ensure that fluctuations in virus mRNA levels do not result in reactivation in 32 
conditions that are unfavourable for viral replication, our data would support this hypothesis.  33 
   34 
Introduction 35 
Malignant catarrhal fever (MCF) is a fatal disease of cattle and other ruminants caused by viruses in 36 
the genus Macavirus of the subfamily Gammaherpesvirinae (Russell et al., 2009). The disease occurs 37 
as a result of infection of susceptible hosts by contact with an asymptomatic carrier species that acts 38 
as a virus reservoir. Ovine herpesvirus-2 (OvHV-2) sub-clinically infects most sheep and is the major 39 
cause of MCF worldwide (Russell et al., 2009). In both sheep and cattle, OvHV-2 infects CD2+ T 40 
lymphocytes (Meier-Trummer et al., 2010; Schock et al., 1998) but only in cattle does virus infection 41 
cause dysregulation of lymphoid cell function leading to uncontrolled proliferation, cytotoxicity and 42 
MCF disease. The proliferation of infected bovine T cells is dependent on the cytokine interleukin-2 43 
(IL-2) and immortalized T cell lines can be cultured from affected cattle. The infected bovine T cells 44 
do not support productive virus replication and have been described as large granular lymphocytes 45 
(LGLs) (Reid et al., 1989) in part due to expression of perforin (Nelson et al., 2010); and unlike 46 
sheep, infected cattle cannot transmit the virus to other susceptible hosts (Russell et al., 2009). The 47 
mechanism by which OvHV-2 induces MCF in cattle is unknown; virus-induced cytopathology is 48 
thought not to be involved in lesion development and it has been proposed that tissue damage arises 49 
from non-antigen specific, MHC unrestricted cytotoxicity of the virus-infected LGLs (Cook & 50 
Splitter, 1988).  51 
MicroRNAs (miRNAs) are short (21-23nt) RNAs that act as post-transcriptional inhibitors of gene 52 
expression. Cellular miRNAs expressed in the nucleus are derived from primary transcripts (pri-53 
miRNAs) that are processed by the enzyme Drosha to form a shorter precursor miRNA (pre-miRNA). 54 
These pre-miRNAs are exported from the nucleus and once in the cytoplasm are further cleaved by 55 
the enzyme Dicer to produce a transient double-stranded precursor; where one strand is designated the 56 
miRNA or guide strand and the complementary strand is designated the miRNA* or passenger strand. 57 
The miRNA is stably incorporated into the RNA-induced silencing complex and guides it to the target 58 
mRNA, which represses translation by a number of mechanisms including mRNA degradation and 59 
inhibition of translation. The interaction of miRNAs with target mRNAs is mediated by a seed region, 60 
nucleotides 2-7 or 2-8 at the 5’end of the miRNA (Bartel, 2009)Most miRNA targets identified to date 61 
are present in the 3’UTR of mRNAs, however some miRNAs have been reported that functionally 62 
target the 5’UTR (Grey et al., 2010; Tay et al., 2009).  63 
To date, over 250 virus-encoded miRNAs have been identified, the majority from herpesviruses 64 
(Grundhoff & Sullivan, 2011). Herpesvirus-encoded miRNAs have been shown to regulate both 65 
cellular and viral gene expression and to influence cell processes including proliferation. In Marek’s 66 
disease virus (MDV), the deletion of a single virus-encoded miRNA abrogates virus-induced cellular 67 
transformation (Zhao et al., 2011) and in Epstein Barr virus (EBV) a cluster of miRNAs has been 68 
implicated in controlling virus-induced B cell proliferation and transformation (Feederle et al., 2011a; 69 
Feederle et al., 2011b; Seto et al., 2010). We have previously demonstrated that OvHV-2 encodes at 70 
least eight miRNAs (Levy et al., 2012) expressed within the immortalized bovine LGL line, BJ1035; 71 
and hypothesize that these play a critical role in MCF pathogenesis. In order to investigate the role of 72 
virus-encoded miRNAs in OvHV-2 pathogenesis it is necessary to identify their viral and cellular 73 
targets. In this study we investigated the role of OvHV-2 encoded miRNAs in regulating selected 74 
virus gene expression. There is no in vitro infection system for studying OvHV-2; the only cells in 75 
which virus gene expression can be studied are immortalized LGL lines like BJ1035 (Levy et al., 76 
2012). All cells in these LGL lines are virus genome positive and in the majority OvHV-2 is latent; 77 
however, some lytic cycle gene expression occurs in a small proportion of the cells (Rosbottom et al., 78 
2002; Thonur et al., 2006).  79 
Results  80 
Prediction of OvHV-2 encoded miRNA targets in the OvHV-2 genome. 81 
Potential miRNA targets within the OvHV-2 genome were initially identified by scanning the entire 82 
OvHV-2 genome using BLASTN (http://blast.ncbi.nlm.nih.gov/Blast.cgi) to align the sequences 83 
complementary to the ovhv2-miRs in the OvHV-2 genome (GenBank, AY839756) (Hart et al., 2007). 84 
Targets were then mapped to the 5’UTR or 3’UTR of OvHV2 genes. Only a small number of OvHV-85 
2 mRNAs have been mapped previously therefore for the majority of genes the 5´UTRs were 86 
considered to span the region from the start codon to the predicted TATA box. For 3’UTRs the region 87 
from the stop codon to the predicted polyadenylation site was used. This analysis identified potential 88 
targets in 33 OvHV-2 genes, representing all classes of virus gene; immediate early, early and late, 89 
and both structural and non-structural proteins.  90 
For validation of predicted targets we focussed on genes/proteins predicted to play important roles in 91 
virus biology and pathogenesis. We chose to analyse targets present in the 5’ or 3’UTR of three virus 92 
genes, ORF 20, ORF 50 and ORF 73. ORF 20 has been shown to induce cell cycle arrest in other 93 
herpesviruses (Nascimento et al., 2009), and the other two genes encode proteins that play contrary 94 
roles in virus latency. ORF 50 is crucial for virus reactivation from latency and ORF 73 is important 95 
for the maintenance of latency (Ackermann, 2006). The positions of the predicted miRNA target sites 96 
in ORF 20, ORF 50 and ORF 73 are detailed in Table 1.  97 
miRNAs function by targeting expressed mRNAs, ORF 20 and 50 are only predicted open 98 
reading frames from the genomic sequence; and the ORF 73 transcript is only partially mapped 99 
(Coulter & Reid). In this study we confirmed the existence of these three virus ORFs as transcripts, 100 
including the miRNA target sites, using an RT-PCR strategy. 101 
The annotated OvHV-2 genome predicts that ORF 20 overlaps with both ORF 19 and ORF 21 (Fig. 102 
1A). To allow detection of ORF 20 only, cDNA synthesis was primed using a gene-specific primer 103 
located 406 bp upstream (42530-41549) of the ORF 19 TATA box (41106). This primer will not 104 
prime ORF 21 mRNA as it is the same sense as the ORF 21 transcript. Fig. 1B shows the 118 bp 105 
amplicon, the sequence of which was 100% identical to the predicted ORF 20 sequence (39294 – 106 
41641) and includes the target sequence (41617 – 41635) for ovhv-2-miR-2 (Fig. 1B).  107 
The ORF 50 and Ov6 transcripts are transcribed in the same direction, with the Ov6 TATA box lying 108 
94 bp downstream of the ORF 50 poly A site. ORF 50 is spliced and ORF 49 lies within the ORF 50 109 
intronic sequence transcribed in the opposite direction (Fig. 1A). We were unable to prime cDNA 110 
synthesis efficiently using an ORF 50 gene specific primer due to the limited number of nucleotides 111 
between the predicted target sequence and the poly A site, we therefore used both oligo dT and 112 
random primers to prime cDNA synthesis. PCR primers (78080-78099 and 79205-79181) were 113 
designed to generate an 1101bp amplicon, from the middle of the second exon of ORF 50 to the poly 114 
A site. The 3’ primer (79025 - 79181) is approximately 1900 bp and 82 bp upstream of ORF 49 and 115 
Ov6 TATA boxes respectively; and the 5’ primer (78080 - 78099) is 118 bp upstream of the Ov6 116 
TATA box and 2304 bp upstream of the Ov6 polyA site. Fig. 1C shows the 1101 bp amplicon the 117 
sequence of which was 100% identical to the predicted ORF 50 and included the target sequence 118 
(79205 - 79181) for ovhv-2-miR-2. 119 
ORF 73 lies downstream of the ORF 75 transcript and is transcribed in the same direction (Fig. 1A).  120 
The annotated OvHV-2 genome (GenBank, AY839756) (Hart et al., 2007) states the 5’ terminus of 121 
the ORF 73 transcript at nt 121049, 31 bp upstream of the predicted poly A site for ORF 75. We used 122 
both oligo dT and random primers to prime cDNA synthesis. PCR primers (120514-120534 and 123 
121060-121041) generates a 536 bp amplicon from within the coding sequence of ORF 73 to the 124 
predicted end of ORF 73 mRNA. Fig. 1D shows this 536 bp amplicon, the sequence of which was 125 
100% identical to the predicted ORF 73 and includes the target sequence (120817-120839) for ovhv-126 
2-miR-8. 127 
Inhibition of gene expression  128 
BJ1035 is a mixed population of cells with respect to virus life cycle; the majority are latently infected 129 
but a small proportion express early and late virus genes (Rosbottom et al., 2002; Thonur et al., 130 
2006). OvHV-2 miRNAs may be also differentially expressed in the proportion of cells in culture in 131 
which the virus is latent compared to those cells where the virus is reactivating making analysis of 132 
inhibition of gene expression following introduction of exogenous miRNAs complex. We therefore 133 
initially assessed the ability of the ovhv2-miRNAs to interact with their predicted targets using a 134 
luciferase expression assay.  135 
We have previously shown that insertion of a predicted 5’UTR downstream of an exogenous 136 
promoter, e.g CMV IE, can result in the expression of transcripts in which the start site does not  137 
reflect that of the native transcript (Grey et al., 2010). In keeping with our previous studies, when 138 
analysing targets in 5’UTRs we cloned a region approximately 1000bp upstream of the AUG in an 139 
attempt to allow correct expression from the natural promoter.  For all experiments a luciferase 140 
expressing vector lacking OvHV-2 sequnces was used to investigate off- target effects: no significant 141 
reduction in luciferase expression was seen using any of the ovhv-2-miRs.  142 
The 5’UTR of ORF 20 contained a predicted target site for ovhv2-miR-2, (Table 1;Fig. 3). BHK-21 143 
cells were co-transfected with reporter constructs and miRNA mimics as described and luciferase 144 
expression levels were measured. The combination of the ORF 20 5’UTR reporter and ovhv2-miR-2 145 
resulted in a 57.5 (± 10) % reduction (p ≤ 0.03) in luciferase expression using 100 nM mimics (Fig. 146 
2a) compared to control miRNA. The same degree of inhibition was observed using 50nM mimics 147 
(data not shown). Ovhv2-miR-2 inhibited luciferase expression by 47.5(±15) % (p ≤ 0.003) even after 148 
the mutation of the predicted target site in the 5’UTR (Fig. 2A), suggesting that inhibition was not due 149 
to interaction of ovhv2-miR-2 with the predicted target sequence. The 3’UTR of ORF 50 was 150 
predicted to contain a target site for ovhv2-miR-5 (Table 1, Fig. 3) the combination of ORF 50 3’UTR 151 
and ovhv2-miR-5 mimic resulted in a 45 (±10) % reduction (p ≤ 0.001) in luciferase expression (Fig. 152 
2B) compared to control miRNA. Mutation of the target site from the 3’UTR abrogated this 153 
inhibition.  154 
The 5’UTR of ORF 73 was predicted to contain two separate sites for ovhv2-miR-8 (Table 1, Fig. 3). 155 
The combination of 5’UTR of ORF 73 and ovhv2-miR-8 mimic resulted in a 45(± 8) % decrease (p ≤ 156 
0.001) in luciferase expression (Fig 2C). Mutation of either of the predicted ovhv2-miR-8 target sites 157 
abolished the inhibitory effect of ovhv2-miR-8.  158 
To further investigate inhibition of the expression of these OvHV-2 genes by the ovhv2-miRs we 159 
developed RT-qPCR assays for ORF 20, 50 and 73 transcripts. BJ1035 cells were transfected with the 160 
relevant ovhv2-miR mimics or control miRNA for 24 or 48h at which point cells were harvested, 161 
RNA isolated and qPCR carried out. We were able to demonstrate a 42(±15) % reduction in levels of 162 
ORF 50 transcript following transfection with ovhv2-miR-5 (Fig. 4a, P=0.042). Although there 163 
appeared to be a 12.8 (±13) % reduction in levels of ORF 20 transcript following transfection with 164 
ovhv2-miR-2 (Fig. 4b), this was not significant (P=0.532). Furthermore, we were unable to 165 
demonstrate any reduction in levels of ORF 73 transcript following transfection with ovhv2-miR-8 (+ 166 
7.3(±13.9) %) (Fig. 4c, P=0.532).  167 
Discussion  168 
OvHV-2 induced malignant catarrhal fever in susceptible hosts is a disease of dysregulated 169 
lymphocyte proliferation and cell function. However, these susceptible hosts cannot transmit the 170 
virus. In contrast, infection of carrier hosts is asymptomatic, but these are infectious. A previous study 171 
has shown that this virus expresses at least eight miRNAs (Levy et al., 2012). In this study we 172 
investigated the control of expression of three virus genes important for control of cell cycle (ORF 20) 173 
and virus latency (ORF 50 and ORF 73) by virus-encoded miRNAs.  174 
The 3’ UTR of ORF 50 was predicted to be targeted by ovhv2-miR-5. This interaction was confirmed 175 
by both the luciferase assay and by inhibition of ORF 50 miRNA levels in BJ1035 cells transfected 176 
with ovhv2-miR-5. Thus we have demonstrated that expression of ORF 50, whose main role is to 177 
drive reactivation from latency, can be inhibited by a viral encoded miRNA. 178 
The 5’UTR of ORF 20 was predicted to contain one site recognised by ovhv2-miR-2. Ovhv2-miR-2 179 
did inhibit luciferase expression; however mutation of the predicted site did not abolish this inhibition. 180 
Thus, whilst we have demonstrated that ovhv2-miR-2 inhibits expression of a transcript containing 181 
the 5’UTR of ORF 20, we cannot definitively show that this inhibition is a consequence of its 182 
interaction with the target site predicted in the original analysis. We also investigated the ability of 183 
ovhv2-miR-2 to inhibit ORF 20 expression in BJ1035 cells. We were able to demonstrate a small 184 
reduction in ORF 20 mRNA levels in BJ1035 cells transfected with this ovhv2-miR-2; however was 185 
not statistically significant.  186 
ORF 73 was predicted to contain two sites recognised by the ovhv2-miR-8 seed sequence located nine 187 
bases apart (Fig. 3). ovhv2-miR-8 was able to inhibit gene expression in the luciferase assay and 188 
mutation of either of these sites resulted in loss of inhibition. Further analysis of the binding of ovhv2-189 
miR-8 to this region using RNAhybrid showed that site 1 was predicted to bind the miRNA with high 190 
efficiency, but RNAhybrid did not identify site 2. Site 2 lies in the region that is likely to interact with 191 
the 3’ end of a miRNA interacting at site 1. It is therefore likely that site 1 is functional and that the 192 
loss of inhibition seen when site two is mutated is due to loss of non-seed sequence interactions. We 193 
were unable to demonstrate any reduction in ORF 73 mRNA levels following transfection of ovhv2-194 
miR-8 into BJ1035 cells.   195 
The inability to demonstrate inhibition of ORF 20 and ORF 73 expression in BJ1035 cells may be due 196 
to a number of factors e.g. the inherent variability within BJ1035 cells could result in variation in 197 
baseline levels of virus gene expression or the ovhv2-miRs may inhibit translation ( the luciferase 198 
assay measured protein levels) of ORFs 20 and 73 without significantly affecting mRNA levels. ORF 199 
73 is the main latency associated protein and so will be expressed in the majority of BJ1035 cells. Our 200 
transfection efficiency for BJ1035s is approximately 40-45% (data not shown) it is possible that the 201 
level of inhibition obtained is not sufficient to be seen under these experimental conditions.  202 
In all three classes of herpesvirus, homologues of ORF 20 (the UL24 family) have been shown to 203 
induce cell cycle arrest and inactivate the cyclin B/cdc2 complex (Nascimento et al., 2009). The 204 
conservation of the structure and function of these proteins during herpesvirus evolution strongly 205 
suggests that they are important in herpesvirus biology (Nascimento et al., 2009 Using ORF 20 206 
deletion mutants of MHV Nascimento et al {Nascimento, 2011 #2962) also demonstrated that ORF 207 
20 is not essential for virus replication, there was a delay in virus clearance from the lungs of animals 208 
infected with the mutant virus and the mutants established latency normally. The role, if any, of ORF 209 
20 in MHV pathogenesis is therefore not clear.  A recent study has shown that viral cyclins play a key 210 
role in control of latency and reactivation of the gammaherpesvirus MHV-68 (Lee et al., 2012). 211 
Different mammalian cyclins could substitute for some of the functions of the MHV-68 cyclins with 212 
different cyclins mediating persistence or reactivation (Lee et al., 2012). It is possible that changes in 213 
expression of ORF 20, mediated in part by ovhv2-miRNAs, could result in a change in the cyclin 214 
expression profile in infected cells influencing the balance between productive and latent life cycles. 215 
A major part of MCF pathogenesis is uncontrolled proliferation of the infected LGLs, whose aberrant 216 
cytotoxic function leads to pathology. Inhibition of ORF 20 expression by ovhv2- miR-2 may down-217 
regulate an ORF 20 mediated block to the cell cycle contributing to the dysregulated lymphocyte 218 
proliferation in susceptible hosts. OvHV-2 miRNAs were identified as being expressed in a bovine 219 
cell line, their expression pattern in infected ovine cells is unknown, however it is possible that a 220 
difference in the regulation of these miRNAs in ovine and bovine cells may result in differences in 221 
expression of ORF 20 leading to the observed differences in the outcome of OvHV-2 infection in 222 
cattle and sheep.  223 
ORF 50 is a homologue of the replication and transcription activator (RTA) of EBV and Kaposi’s 224 
sarcoma herpesvirus (KSHV). In KSHV, the virus encoded miR-K5 and miR-K9 have antagonistic 225 
effects on latency. miR-K5 attenuates expression of RTA leading to a reduction in reactivation whilst 226 
miR-K9 targets BCLAF-1, a host transcription factor that is associated with reduced viral replication 227 
(Ziegelbauer et al., 2009).  Using a PARclip approach Gottwein et al. (Gottwein & Cullen, 2010) 228 
have reported that ORF 73 of KSHV is targeted by KSHV miR-K10/miR-142- 3p.  Deletion of three 229 
EBV-encoded miRNAs has been shown to result in a significant increase in expression of virus latent 230 
genes (Feederle et al., 2011a; Feederle et al., 2011b; Seto et al., 2010) and Riley et al. (Riley et al., 231 
2012) have shown that EBV-encoded miRNAs target virus-encoded, latency-associated genes and 232 
suggested that these miRNAs play a role in control of EBV latency. The OvHV-2 immortalized LGL 233 
cell line, BJ1035 is a mixed population of cells with respect to virus life cycle; the majority are 234 
latently infected but a small proportion express early and late virus genes(Rosbottom et al., 2002; 235 
Thonur et al., 2006). Thus, OvHV-2 miRNAs may be differentially expressed in the proportion of 236 
cells in culture in which the virus is latent compared to those cells where the virus is reactivating.  237 
The proteins encoded by ORF 50 and ORF 73 play important, but contrary roles in relation to latency; 238 
ORF 50 is critical for virus reactivation and ORF 73 is important in maintenance of viral latency 239 
(Ackermann, 2006). Bellare and Ganem (Bellare & Ganem, 2009) proposed that miRNA-induced 240 
inhibition of virus genes is not the sole regulator of reactivation/latency but rather that they ensure 241 
that fluctuations in virus mRNA levels do not result in reactivation in conditions that are unfavourable 242 
for viral replication, i.e. the miRNAs act as a type of rheostat to control the levels of virus gene 243 
expression. The apparent contradiction of having miRNAs that act to both inhibit and encourage 244 
reactivation expressed in the same cell line can be explained by considering the mixed nature of the 245 
BJ1035 line. The differential expression of individual virus miRNAs in individual cells could respond 246 
to changes in the cellular environment acting to regulate virus gene expression . The factors which 247 
determine the maintenance of, or reactivation from, latency, are complex, by demonstrating miRNA 248 
mediated control of both “pro and anti- reactivation genes” our data adds support to the hypothesis 249 
that miRNAs represent an additional layer of control exerted by the virus to control the latent state.  250 
 251 
Methods  252 
Target identification. Potential miRNA targets within the OvHV-2 genome were identified using 253 
BLASTN (http://blast.ncbi.nlm.nih.gov/Blast.cgi) to align the sequences complementary to the 254 
ovhv2-miRs in the OvHV-2 genome (GenBank, AY839756) (Hart et al., 2007). Targets were mapped 255 
to the 5’UTR or 3’UTR of OvHV2 genes. Only a small number of OvHV-2 mRNAs have been 256 
mapped previously therefore, for the majority of genes, the 5´UTRs were considered to span the 257 
region from the start codon to the predicted TATA box. For 3’UTRs the region from the stop codon to 258 
the predicted polyadenylation site was used. Sites chosen for validation were also analysed by 259 
RNAhybrid (Rehmsmeier et al., 2004) allowing no G:U pairing in the seed sequence and a helix 260 
constraint of nucleotides 2 to 8.  261 
 Cell culture. Baby hamster kidney cells (BHK-21) were cultured in Glasgow’s minimum essential 262 
medium (Gibco) supplemented with 10% new born calf serum, 1% v/v Penicillin/Streptomycin, 1% 263 
v/v L-glutamine (Sigma) and 10% v/v tryptose phosphate broth. BJ1035 cell were grown in 264 
suspension in Iscove’s Modified Dulbecco’s Medium (Invitrogen) (Hart et al; 2007) supplemented 265 
with 10% v/v FCS, 1% v/v penicillin/streptomycin and 350 U ml-1 Proleukin (IL-2) (Novartis 266 
Pharmaceutical) and cultured at 37oC with 5% CO2.  267 
Cloning of target sites. Sequences spanning the 3’ and 5’ UTRs of the selected genes were amplified 268 
by PCR (Fig S1). For 3’UTRs the region from the stop codon to the predicted poly A site was 269 
amplified, for analysis of 5’UTRs approximately 1000 bp upstream of the ATG was amplified, 270 
3´UTRs were cloned into the psiCHECKTM-2 Vector (Promega) downstream of a renilla luciferase 271 
reporter gene (Rluc) and 5´UTRs into the pGL4.10 vector (Promega) upstream of a firefly luciferase 272 
reporter gene (Fluc).  273 
Transfection. BHK-21 cells (n=6) were co-transfected with reporter vectors (1.5 g) with or without 274 
the 5’ or 3’UTR of interest and with 50 nM or 100 nM mimic miRNAs (miScript miRNA Mimics, 275 
Qiagen) or control miRNA (AllStars Negative Control siRNA, Qiagen) using Lipofectamine 2000 276 
(Invitrogen) (Mimic sequences: ovhv2-miR-2 , 5'-AUCUUGGACGCAUCUGUCAGUAG-3'; ovhv2-277 
miR-5 , 5'-UGAAGUUACAGCUGCACCUGGAU-3'; ovhv2-miR-8 ,  278 
5'- UGGCUCAGCGUGACUGCUCUUC-3'). After 24 h, samples were harvested and luciferase 279 
levels assessed using the Dual-Luciferase Reporter Assay System (Promega). For psiCheck (3’UTR) 280 
based vectors Rluc (target) expression was normalized to Fluc expression from the same plasmid. For 281 
pGL4.10 (5’UTR) based vectors, cells were co-transfected with the pRL vector (Promega) to allow 282 
normalization of Fluc expression. BJ1035 cells were prepared for transfection by density –gradient 283 
centrifugation using lymphoprep (Axis-Shield) and re-suspended at a concentration of 1x 106 cells in a 284 
final volume of 100ul of solution V (Lonza). 200 nM of mimic or control miRNA were transfected 285 
into the prepared cells using program X-001 of Nucleofector II (Lonza). Transfected cells (n=3) were 286 
incubated for 24 hrhr in BJ1035 media prior to RNA extraction. 287 
Site directed mutagenesis. Site directed mutagenesis was performed using the Quick Change Site-288 
Directed Mutagenesis (Stratagene) protocol. Primers for mutagenesis (HPLC purified, Eurofins MWG 289 
Operon, Germany) were designed such that each primer was 42-45 nt in length, with a Tm of >78oC. 290 
(Table S1). All mutations were confirmed by sequencing.  291 
cDNA synthesis. RNA was isolated from BJ1035 cells using an RNeasy kit (Qiagen). 1 μg RNA was 292 
digested with RQ1 DNase (Promega) for 30 min at 37 ˚C. For analysis of ORF 20, cDNA was primed 293 
with 250 ng or 66 ng of specific primer (41530 - CTGAAACATGGCCTCCAACT -41549).For 294 
analysis of ORF 50, cDNA was primed using 250 ng oligo dT primer or random primers (Promega; 295 
equivalent to 0.5 g.g-1 RNA). cDNA was synthesized using AMV reverse transcriptase for 1 hr at 296 
42 ˚C (oligo dT and specific primer) or 37 ˚C (random primer).  297 
 RT-PCR analysis of transcripts. ORF 20 cDNA was amplified with primer pair 298 
TTCATAGTCACTGTTGTCC and CTGAAACATGGCCTCCAACT (nt 41617-41635 and 41530-299 
41549). ORF 50 cDNA was amplified with the primer pair CCCCAACAAGTCAGCATTTT and 300 
CACTTTTATTTTAACATCACAAACC (nt 78080-78099 and 79205-79181). ORF 73 cDNA was 301 
amplified with the primer pair CCACTTCGTAAAAGCACCATT and 302 
GTAATCCTGCCCCAGCTGTA (nt 120514-120534 and 121060-121041). PCR reactions contained 303 
8 pM primers, 120 µM dNTPs, 1 U HotStar Taq plus (Qiagen) in a final reaction volume of 25 µl. 304 
Following an initial denaturation of 5 min at 95 ˚C, 40 cycles (30 s at 95 ˚C, 30 s at 58 ˚C and 1 min 305 
15 s at 72 ˚C) were performed prior to a final extension of 5 min at 72 ˚C. 100 ng of BJ1035 DNA 306 
was used as a positive control for the PCR. Samples were run on a 2% agarose gel and visualized, 307 
extracted, cloned into pCR2.1-Topo (Invitrogen) and sequenced. 308 
RT-qPCR. RNA was isolated using an RNeasy kit (Qiagen). 1 g of RNA was digested with RQ1 309 
Dnase (Promega) for 30 min at 37 ˚C. cDNA was primed using 250ng Oligo dT primer (Promega; 310 
equivalent to 0.5 g/g RNA) and synthesized using AMV reverse transcriptase for 1 hr at 42 ˚C. 311 
Semi-quantitative PCR was performed on a Rotorgene Q machine (35 cycles of 15 s 95 ˚C, 30 s 58 ˚C 312 
and 30 s 72 ˚C) using SensiFAST™ SYBR Hi-ROX One-Step master mix (Bioline), 2µl of diluted 313 
cDNA (1:10) and specific primers for GAPDH (Gossner et al., 2009), ORF 20 314 
(CACTACCCAGCGCTCTTCC (41125-41143); TTGTACCCAACCCCATCAAG (41237-41218); 315 
ORF 50 (CCCCAACAAGTCAGCATTTT (78080-78099); TCAGGGGTGACTCCAATG (78267-316 
78250) and ORF 73 (CAG GGCAAAACGTAA AAAGC (119367-119348); GTGTGGAGC 317 
GTTAGGATTG (119223-119241) at a final concentration of 8 pM in a final reaction volume of 20 318 
μl. Transcript levels were normalised to GAPDH and the relative expression was calculated using 2-319 
ΔΔCt (Livak & Schmittgen, 2001). Three technical replicates were performed for each biological 320 
replicate. Data were plotted as fold change in relation to negative control.  321 
Statistics. For Luciferase assays groups were compared using single factor analysis of variance 322 
(ANOVA) test followed by Tukey’s post-hoc test. P values represent results from the post-hoc test. 323 
To compare levels of ORF 20, ORF 50 or ORF 73 transcripts after transfection ovhv2-mirs standard 324 
linear mixed effect (LME) statistical models were used. Technical replicates were entered as random 325 
effects to account for the repeated sampling of the same cell line. Whether the data was test or control 326 
was entered as the fixed effect. For ORF 50 and ORF 73 three independent runs were performed, and 327 
this run parameter was entered as a potential confounding fixed effect prior to control/test status. 328 
Examination of residuals demonstrated a normal distribution. The LME were carried out in R (version 329 
2.15.0 © 2012 The R Foundation for Statistical Computing). 330 
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 411 
  412 
Figure. legends 413 
Fig. 1   414 
A. Genomic location of ORF 20 and ORF 50 relative to adjacent genes.  415 
Genes are indicated by open boxes, arrow head represents direction of transcription. Dotted lines 416 
represent introns. The nucleotide positions representing the location of the predicted TATA box and 417 
poly A site for each gene are indicated. The position of primers used for PCR and cDNA priming 418 
(ORF 20) are indicated by arrows and nucleotide position. Predicted miRNA binding sequences are 419 
indicated by vertical bars in the respective UTRs. 420 
B. ORF 20 Lane 1, No RT; Lane 2, cDNA primed with 35 pm primer (250 ng); Lane 3, cDNA 421 
primed with 10 pm primer (66ng); Lane 4,: No template control; Lane 5, DNA positive control. Lane 422 
6; Marker, Generuler 100bp  423 
C. ORF 50 Lane 1, No RT, Lane 2, cDNA primed with Oligo dT; Lane 3 , cDNA primed with 424 
random primers; Lane 4, No template control; Lane 5, DNA positive control; Lane 6, Marker, 425 
Generuler 1kb 426 
D. ORF73 Lane 1, No RT, Lane 2, cDNA primed with Oligo dT; Lane 3 , cDNA primed with random 427 
primers; Lane 4, No template control; Lane 5, DNA positive control; Lane 6, Marker, Generuler 428 
100bp 429 
 430 
 431 
Fig. 2 BHK cells (n=6) were co-transfected with: a) PGL-ORF 20, which has the 5’UTR of ORF 20 432 
upstream of firefly luciferase (or with a PGL-ORF 20 in which the predicted ovhv2-miR-2 target site 433 
had been mutated), pRL (which expresses renilla luciferase) and either an ovhv2-miR-2 mimic or a 434 
scrambled miRNA control: b) psi-ORF 50, which has the 3’UTR of ORF 50 downstream of renilla 435 
luciferase (or with a psi-ORF 50 in which the predicted ovhv2-miR-5 target site had been mutated), 436 
and either an ovhv2-miR-2 mimic or a scrambled miRNA control: c) PGL-ORF 73, which has the 437 
5’UTR of ORF 73 upstream of firefly luciferase (or with a PGL-ORF 73 in which the predicted 438 
ovhv2-miR-8 target sites had been individually mutated), pRL (which expresses renilla luciferase) and 439 
either an ovhv2-miR-8 mimic or a scrambled miRNA control 24 h post-transfection firefly luciferase 440 
levels were measured, normalised to the renilla luciferase levels and expression in the control and test 441 
miRNA samples compared.  442 
 443 
Fig. 3  444 
A) RNAhybrid analysis of the predicted target sites with the relevant miRNA.  445 
mfe = mean free energy. 446 
B) Sequence of ORF 73 5’UTR surrounding predicted sites 1 and 2 (underlined) the shaded box 447 
represents the sequence shown to interact with ovhv2-miR-8 in A.  448 
 449 
 450 
 451 
Fig. 4  452 
BJ1035 cells (n=3) were transfected with control miRNA mimic or; A)  453 
ovhv2-miR-5 mimic, B) ovhv2-miR-2 mimic, D) ovhv2-miR-8 mimic.  Twenty four hrhr post 454 
infection RNA was extracted and transcript levels of a) ORF 50, b) ORF 20 and c) ORF 73 analysed 455 
by RT-qPCR (3 technical replicates per biological replicate). Levels were compared to levels in 456 
control transfected cells; error bars represent the standard error of the mean levels as produced by the 457 
linear mixed-effect statistical models, taking into account the technical and biological replicates. 458 
 459 
  460 
  461 
Table 1  462 
 463 
Gene  5’UTR  3’ UTR  5’ UTR targets  3’ UTR targets 
ORF 
20  41641‐41538    ovhv2‐miR‐2 : 41611‐7   
ORF 
50    79043‐79196    ovhv2‐miR‐5 : 79161‐7 
ORF 
73  121049‐120533   
ovhv2‐miR‐8 : 120824‐18 
       : 120840‐34   
 464 
 465 
 Nucleotide numbers are from (GenBank, AY839756) (Hart et al., 2007). 466 
 467 
 468 
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a 
ORF 20  
         41627  5'   C    U       CCUCCUC       U 3' 41605 
                      ACUG     UGU       CCAAGAU     
                      UGAC     ACG       GGUUCUA     
Ovhv2-miR-2      3' GA    UGUCU   CA              5' 
 
mfe: -16.9 kcal/mol 
 
ORF 50  
    79144   5'  C    AAAU   A  U          C 3'   79168 
                 CCAG    GUG CA    UAACUUC     
                 GGUC    CAC GU    AUUGAAG     
Ovhv2-miR-5 3' UA              CGAC       U 5' 
mfe: -17.8 kcal/mol 
 
ORF73 site 1 
     120817  5' U   CCU         U       U 3'  120839 
                 GAG   GCAG C CG CUGAGCC     
                 UUC   CGUC G GC GACUCGG     
Ovhv2-miR-8  3' C   U      A U          U 5' 
 
mfe: -27.4 kcal/mol 
 
 
b 
                                                                                               
                                                  Site 1 
 AUUACGUCCCGACAUCCCGGGACCUGAGCCUGCAGCCGUCUGAGCCUUUUCUAAAA  
                     Site 2 
 
Figure 3
020
80
60
40
100
Re
la
tiv
e t
ra
ns
cr
ip
t le
ve
l
Ovhv‐2‐miR‐5       Control  Ovhv‐2‐miR‐2       Control 
0
20
80
60
40
100
Re
la
tiv
e t
ra
ns
cr
ip
t le
ve
l
Ovhv‐2‐miR‐8       Control 
0
20
80
60
40
100
Re
la
tiv
e t
ra
ns
cr
ip
t le
ve
l
P= 0.042 P= 0.532P= 0.532
Figure 4
a) ORF 50  c) ORF 73 b) ORF 20 
